REPL (REPL) Stock Price & Analysis
REPL (REPL) rose 0.00% to USD 9.7 as of July 25, 2026 at 03:48 UTC, according to Nexqual real-time market data.
REPL last closed at USD 9.7; the session ranged USD 9.65–10.36 on volume of 3,266,046 shares. Market capitalization is —, with a 52-week range of USD 1.5–12.5 (NMS). Source: Nexqual, July 25, 2026 at 03:48 UTC.
Key Statistics (as of July 25, 2026 at 03:48 UTC)
| Price | USD 9.7 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 9.7 |
| Open | USD 9.7 |
| Day Range | USD 9.65 – 10.36 |
| 52-Week Range | USD 1.5 – 12.5 |
| Volume | 3,266,046 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (REPL)
Nexqual's technical model rates REPL "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 03:48 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 43.62 (neutral) |
| vs SMA50 | Above (USD 9.04) |
| MACD | 0.25 (positive) |
From REPL's Latest SEC 10-K Filing (filed 2026-06-29)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SRRK | Scholar Rock Holding Corporatio | USD 47.67 | ▼ 1.3% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 83.73 | ▲ 0.01% |
| STOK | Stoke Therapeutics, Inc. | USD 29.3 | ▲ 1.17% |
| SNDX | Syndax Pharmaceuticals, Inc. | USD 20.81 | ▼ 5.62% |
| IDYA | IDEAYA Biosciences, Inc. | USD 35.4 | ▲ 1.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:48 UTC. This page is informational and not investment advice.